Newly diagnosed Multiple Myeloma in patients eligible for stem cell transplantation research hub

Accelerate Improvement in Multiple Myeloma for Newly Diagnosed Transplant-Eligible Patients (AugMMent)

This study, called AugMMent, is looking at new ways to treat multiple myeloma, a type of blood cancer, in people who have recently been diagnosed and are well enough for a stem cell transplant. It aims to see if combining different medicines can make the treatment more effective.